The approval of perpetual futures contracts in the US may lead to unforeseen tax and regulatory challenges for traders if these contracts are ultimately deemed swaps rather than futures, warns CME Group Chairman and CEO Terry Duffy. In an interview, Duffy emphasized the ambiguity surrounding the tax implications for US participants. The comments come as CME continues to challenge the Commodity Futures Trading Commission's approval of perpetual futures contracts, with the outcome potentially influencing the US approach to this rapidly growing market. The core issue revolves around whether perpetual futures should be legally treated as futures or swaps, with Duffy arguing they should be classified as swaps due to the periodic funding payments between long and short positions.
This classification discrepancy could lead to institutional traders receiving blended tax treatment under Section 1256 of the US tax code, treating gains and losses as 60% long-term and 40% short-term capital gains, if they are considered futures. However, if classified as swaps, they would be taxed under 'ordinary' taxation, leading to potential uncertainty for market participants who have been treating them as futures for tax purposes. Legal experts note the complexity of the issue, highlighting that while perpetual futures structurally resemble swaps, they function economically like futures, making it a 'substance-over-form' question. The broad definition of swaps adds to the ambiguity, leaving considerable room for interpretation regarding its application to new financial products like perpetual futures.
The outcome will depend on the court's interpretation, with the potential for extensive litigation and the need for separate guidance from the IRS, which may not adopt the CFTC's interpretation. Until clarity is provided, large institutions may face uncertainty over reporting trades involving perpetual futures, potentially leading to tax implications.